Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Fulcrum Therapeutics Inc. (FULC)

4.46   -0.11 (-2.41%) 10-21 16:00
Open: 4.67 Pre. Close: 4.57
High: 4.68 Low: 4.39
Volume: 24,120 Market Cap: 104M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.711 - 4.756 4.756 - 4.783
Low: 4.297 - 4.354 4.354 - 4.389
Close: 4.394 - 4.488 4.488 - 4.544

Technical analysis

as of: 2019-10-21 4:36:22 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.16     One year: 11.66
Support: Support1: 4.39    Support2: 3.65
Resistance: Resistance1: 7.84    Resistance2: 9.98
Pivot: 5.54
Moving Average: MA(5): 4.70     MA(20): 6.02
MA(100):     MA(250):
MACD: MACD(12,26): -1.28     Signal(9): -1.27
Stochastic oscillator: %K(14,3): 2.74     %D(3): 3.17
RSI: RSI(14): 18.64
52-week: High: 14.99  Low: 4.39  Change(%): -67.0
Average Vol(K): 3-Month: 6109  10-Days: 4358

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
FULC has closed above bottom band by 16.2%. Bollinger Bands are 0% narrower than normal.

Headline News

The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 17) Applied Therapeutics Inc (NASDAQ: APLT ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Celgene Corporation (NASDAQ: CELG ) Kodiak Sciences Inc (NASDAQ: KOD ) The Medicines Company (NASDAQ: MDCO ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 17) Aileron Therapeutics Inc (NASDAQ: ALRN ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Homology Medicines Inc (NASDAQ: FIXX ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Neurometrix Inc (NASDAQ: NURO ) (reacted to its third-quarter results) Puma Biotechnology Inc (NASDAQ: PBYI ) Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Theratechnologies Inc (NASDAQ: THTX ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Stocks In Focus Intuitive Surgical Q3 Tops Expectations Intuitive Surgical, Inc. (NASDAQ: ISRG ) reported third-quarter earnings per share of $3.43 on revenues of $1.13 billion.

The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 15) Celgene Corporation (NASDAQ: CELG ) Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) Kodiak Sciences Inc (NASDAQ: KOD ) The Medicines Company (NASDAQ: MDCO ) Natera Inc (NASDAQ: NTRA ) Ra Pharmaceuticals Inc (NASDAQ: RARX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) (announced positive results for a Phase 2 study of its drug to treat Friedreich ataxia) Relmada Therapeutics Inc (NASDAQ: RLMD ) ( announced positive Phase 2 results for drug to treat treatment-resistant depression) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 15) Auris Medical Holding Ltd (NASDAQ: EARS ) BENITEC BIOPHAR/S ADR (NASDAQ: BNTC ) Chimerix Inc (NASDAQ: CMRX ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Heat Biologics Inc (NASDAQ: HTBX ) INmune Bio Inc (NASDAQ: INMB ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Karuna Therapeutics Inc (NASDAQ: KRTX ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM ) Novus Therapeutics Inc (NASDAQ: NVUS ) Orgenesis Inc (NASDAQ: ORGS ) Phio Pharmaceuticals Corp (NASDAQ: PHIO ) Precision BioSciences Inc (NASDAQ: DTIL ) Pulmatrix Inc (NASDAQ: PULM ) Sierra Oncology Inc (NASDAQ: SRRA ) Strongbridge Biopharma plc (NASDAQ: SBBP ) Stocks In Focus Akebia Sues CMS For Restoring Coverage For Kidney-Disease Related Anemia Drug Akebia Therapeutics Inc (NASDAQ: AKBA ) has filed a compliant in federal district court against the Centers of Medicare & Medicaid Service and the U.S.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 23.34
Shares Float (M) 15.15
% Held by Insiders
% Held by Institutions
Shares Short (K) 110
Shares Short P. Month (K)

Stock Financials

EPS -50.400
Book Value (p.s.) -59.710
PEG Ratio -0.27
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.874
Qtrly Earnings Growth
Operating Cash Flow (M) -32.49
Levered Free Cash Flow (M)

Stock Valuations

P/E -0.09
P/E Growth Ratio -0.02
P/BV -0.07
P/CF -3.20

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.